The efficacy of various kinetic models to pre dict time courses of total radioactivity and levels of pre cursor and metabolic products was evaluated in hetero geneous samples of freeze-blown brain of rats adminis tered [14C]deoxyglucose ([14C]DG). Two kinetic models designed for homogeneous tissues, i.e., a no-product loss, three-rate-constant (3K) model and a first-order product-loss, four-rate-constant (4K) model, and a third kinetic model designed for heterogeneous tissues without product loss [Tissue Heterogeneity (TH) Model] were ex amined. In the 45-min interval following a pulse of p4C]DG, the fit of the TH Model to total tissue radioac tivity was not statistically significantly better than that of the 3K Model, yet the TH Model described the time courses of [14C]DG and its metabolites more accurately. The TH-and 4K-Model-predicted time courses of
The measurement of the rate of a biochemical process with a radioactive tracer in vivo requires a model that describes the kinetics of the equilibra tion of the precursor pool in tissue with that in plasma and the accumulation of radioactive prod- [14C] DG and its metabolites were similar. Whole-brain glucose utilization (CMRglc) calculated with the TH or 3K Model, �75f.,lmol 100 g-I min-I, was similar to values previously determined by model-independent techniques, whereas CMRglc calculated with the 4K Model was 44% higher. In a separate group of rats administered a pro grammed infusion to attain a constant arterial concentra tion of [14C]DG that minimizes effects of tissue heteroge neity as well as any product loss, CMRglc calculated with all three models was 79 f.,lmol 100 g -I min -I at 45 min after initiation of the infusion. Statistical comparisons of goodness of fit of total tissue radioactivity were, there fore, not indicative of which models best describe the tissue precursor and product pools or which models pro vide the most accurate rates of glucose utilization. Key Words: Deoxyglucose-Kinetic modeling.
ucts. Rate constants of the kinetic model are usually determined by fitting the model equations to an ex tended time course of measured total tissue radio activity. The rate constants are then used to esti mate the precursor-product relationship in the tis sue and thence the rate of the process of interest from measurements of plasma and total tissue ra dioactivity. When tissue activities are determined by external counting or by quantitative autoradiog raphy, it is not possible to verify directly the pre cursor-product relationship, and so the validation of the kinetic model has usually rested on how well the model describes total tissue radioactivity and how closely the model-derived rates compare with rates determined by model-independent means . The ability of a kinetic model to predict accurately total tissue radioactivity does not, however, necessarily imply that the model provides an accurate descrip-tion of the time courses of the levels of precursor and metabolites in tissue or an accurate estimation of the rate of the process of interest . Por example, it was previously shown in simulation studies that a e4C]deoxyglucose ([14C]DG) kinetic model de signed for measurement of rates of cerebral glucose utilization (CMRglc) in homogeneous tissue but ap plied in a metabolically heterogeneous brain tissue produces inaccurate estimates of precursor and product time courses (Nelson et aI ., 1987; Schmidt et aI ., 199 1a) . A model that provided a more accu rate precursor-product time course, but assumed that there was loss of metabolic product when, in fact, there was none, led to overestimation of CMRglc (Schmidt et aI ., 199 1a) . In human studies with [18P]fluorodeoxyglucose ([18p] PDG) and posi tron emission tomography (PET), kinetic models were found to be discrepant in how well they fitted the time course of total tissue radioactivity and how accurately they determined CMRglc (Schmidt et aI ., 1992; Lucignani et aI., 1993) .
Each of the studies cited above has inherent lim itations, but it is clear that prediction of total radio activity is not sufficient for validation of a kinetic model . Interpretation of results from simulation studies of tracer kinetics is limited by uncertainty in knowing how well the assumed model and parame ter set used to describe the behavior of the tracer depict the true kinetics of the tracer in tissue. PET studies cannot measure directly the concentrations in the tissue precursor and product pools . In the present study, we sought to validate by direct chemical measurements in heterogeneous rat brain tissue the model-predicted kinetics of the uptake and metabolism of ['4C]DG. We analyzed various kinetic models of e4C]DG to elucidate the relation ship between measured and model-estimated time courses of the levels of [14C]DG in the precursor pool in heterogeneous brain tissue and the product pool consisting of [14C]deoxyglucose-6-phosphate ([14C]DG-6-P) and its further metabolites in the tis sue . We sought to determine also which model pro vided the most accurate rates of glucose utilization . The tracer was administered as either an intrave nous pulse or a programmed infusion designed to achieve and maintain a constant arterial plasma concentration of ['4C]DG, thereby minimizing the effects of tissue heterogeneity as well as product loss, if any . The kinetic models examined included two originally designed for use in homogeneous tis sue, i.e., the three-rate-constant (3K) model of Sokoloff et a1. (1977) that assumes no loss of [14C]DG-6-P and a four-rate-constant (4K) model that includes a first-order rate constant for loss of [,4C]DG-6-P (Phelps et aI., 1979) . We also examined for comparison a model specifically designed for heterogeneous tissues [Tissue Heterogeneity (TH) Model] that includes no loss terms (Schmidt et aI., 199 1a) . 
MATERIALS AND METHODS

Chemicals
Experimental protocol
Experiments were carried out on male Sprague Dawley rats weighing 250-375 g (Taconic Farms, Ger mantown, NY, U.S.A.). Under halothane anesthesia 0.2%; 70% N20/30% 02)' polyethylene catheters (PE-50) were inserted into a femoral artery and vein . Animals were then allowed to recover from anesthesia for at least 2 h. Mean arterial blood pressure was measured with an air-damped Hg'manometer . Arterial blood pH, P02, and Pe02 were measured with a Corning model 158 pH/Blood Gas Analyzer (Corning Medical and Scientific, Medfield, MA, U.S.A.). Arterial blood pressure, blood gases, and hematocrit were measured just prior to administration of tracer. Glucose concentration in plasma was measured directly by the glucose oxidase method with a Glucose Analyzer II (Beckman Instruments, Fullerton, CA, U.S.A.). In the first series of experiments, a pulse of 125 fLCi [14C]DG/kg body wt was administered intravenously (pulse experiments; n = 21) in awake, freely moving rats (Crane and Porrino, 1989) . Timed arterial blood samples were collected at progressively increasing time intervals and immediately centrifuged to separate blood cells from plasma. At 3, 5, 10, 15, 25, 45,  or 60 min, the animal was placed in a restraint and the experiment was immediately terminated by freeze-blowing of the brain (Veech et al., 1973) . Freeze-blowing of the brain provided a sample of a kinetically heterogeneous mixture of gray and white mat ter from the whole brain anterior to the cerebellum . In a second series of experiments, awake, freely moving rats were administered [14C]DG by a ramp infusion for 5 min followed by a programmed intravenous infusion to achieve and maintain constant arterial [14C]DG levels (square wave experiments; n = 26) . The initial ramp in fusion was given to improve the sensitivity in the estimate of the influx rate constant, whereas the subsequent con stant arterial e4C]DG levels were chosen to minimize the effects of tissue heterogeneity as well as any product loss. At 3, 5, 10, 15, 25, 35, 45, or 60 min, experiments were terminated by freeze-blowing of the brain. Animals used in experiments terminated at 3 or 5 min were adminis tered 250 fLCi [14C]DG/kg body wt; all others were given 125 fLCi/kg .
Tissue extraction and metabolite assays
The frozen brains were powdered under liquid nitrogen in a cryostat maintained at about -35°C and divided into weighed 100-to 200-mg portions . One portion of each brain was solubilized by incubation in 2 ml Protosol at 35°C overnight and assayed for its total 14C content by liquid scintillation counting with external standardization (model LS 5801; Beckman Instruments) . Another portion of each brain was extracted with ethanol/phosphate buffered saline/water (65: 10:25, by vol) as described by Dienel et al. (1991) ; ethanol extraction is necessary to avoid degradation of acid-labile metabolites of [ 14C]DG during the extraction procedure. The ethanol extracts were stored at -80°C until assayed for their contents of [ 14C]DG and 14C-Iabeled metabolites after separation of [ 14C]DG from other 14C-Iabeled compounds on a Carbo Pac PAl anion-exchange column with a BioLC HPLC system (Dionex Corp., Sunnyvale, CA, U.S.A.) as pre viously described (Dienel et a!., 1993) . Labeled metabo lites in addition to [ 14C]DG-6-P are present in brain tissue; most of these compounds, except deoxysorbitol, which is present in very small amounts, are derived from e4C]DG-6-P and are also phosphorylated (Dienel et a! ., 1993) . For convenience in the following discussion of kinetic models, [ 14C]DG-6-P refers to the total metabolite pool in brain .
Determination of levels of [14C]DG and e4C]DG-6-P in tissue and plasma
Total radioactivity measured in the tissue was cor rected for radioactivity in the blood in the brain as fol lows:
where C� ssue( I) is the total 14C concentration in the tis sue, WB/WT is the fraction of the total brain mass con tributed by the blood in the tissue, and Ci3(I) is the con centration of radioactivity measured in the arterial blood at the end of the experimental period. WB/WT was not measured in the current study; the value of 2.6% deter mined by Veech et al. (1973) for freeze-blown rat brain was used . The concentration of free [ 14C]DG in tissue, C:(I), was determined from the [ 14C]DG concentration measured in the tissue extract by correcting for the amount of [ 14C]DG in the blood in the brain as follows:
C�I) = C clssu e DoC I) -C 6IoodDG (I) (WB/WT)
-WB/WT
(2)
where C�ssue DG(I) is the concentration of e4C]DG in the tissue extract and C�loodDG(I) is the concentration of [ 14C]DG in the arterial blood. The concentration of free e4C]DG in blood was not measured, but its value is bounded by the measured concentrations of [ 14C]DG in plasma and total 14C in whole blood. Because the mean difference between C: corrected for the plasma e4C]DG concentration and that corrected for the concentration of total 14C in whole blood was only 2%, C: was corrected for the concentration of [ 14C]DG in plasma only. The con centration of [ 14C]DG-6-P and its further metabolites, C:;'(I), was determined by C:;'(1) = C�ssue (1) -Q ssue DG(1)
In the pulse experiments, the concentration of total14C in the arterial plasma was corrected for the presence of me tabolites as previously reported by Dienel et a! . (1993) . The metabolite fractions in arterial plasma were 2, 3, 9, and 10% at 25, 35, 45, and 60 min after the intravenous pulse of [ 14C]DG. The time course of the fraction of me tabolites in the arterial plasma was not measured in square wave experiments, but 45 min after initiation of a programmed infusion, -10% of the label in the arterial J Cereb Blood Flow Metab, Vol, 15, No .3, 1995 plasma was found to be in metabolites in normoglycemic rats (Dienel et a!., 1991) . No corrections for the time course of labeled metabolites in arterial plasma were made in the current square wave experiments .
Kinetic models
The 3K ) (4) where C;(t) is the concentration of e4C]DG in the arterial plasma (nCi/m!); Kf (ml g-l min-I) and ki (min-I) are the rate constants for influx of [ 14C]DG from the plasma to the tissue and for efflux from the tissue to the plasma, respectively; and k� (min -I) is the rate constant for phos phorylation of [ 11C]DG to e4C]DG-6-P. Total concentra tion ,of 14C in the tissue at any time t, Cr(t), is the sum of C:(t) and C:;,(t). C't(t) , C:(t), and C:;,(t) are expressed in nanocuries per gram.
The 4K homogeneous tissue model (Phelps et a!., 1979) ( Fig . IB) is given by
where C;(t), C:(t), C:;,(t), Kf, ki, and k� are as described above. The rate constant for dephosphorylation of
[ 14C]DG-6-P to [ 14C]DG, k: (min -I), was originally in corporated into the kinetic model for use with very long experimental periods in which loss of labeled products becomes significant . It has been shown that when either of the homogeneous tissue models is applied to a heterogeneous tissue, the rate constants for efflux and phosphorylation of [ 14C]DG, ki and k�, respectively, decline with time after a pulse of [ 14C]DG as a direct consequence of tissue heterogeneity (Schmidt et a!., 1991a (Schmidt et a!., , 1992 . This was taken into account in the development of a kinetic model for the behavior of [ 14C]DG in heterogeneous tissues in which the constant parameters ki and k� were replaced with exponentially declining effective rate "constants, " ki(t) and k�(t), as follows (Schmidt et a! ., 1991a): assumed that a constant fraction, k: (min -1), of the total pool of [ 14C]DG-6-P recycles back to the precursor pool per unit time. C: Tissue Heterogeneity (TH) 1I!0d� in whi� there is no loss of [ 14C]DG-6-P. In this model, C;, C;", and C; represent the mass-weighted average C4C]DG, 14C-labeled metabo lites, and total 14C concentration� (nCilg) in the heteroge neous brain tissue, respectively. K1 (ml g -2 min -1) is the mass-weighted average influx rate constant, k� (min -1) is the mass-and precursor-pool-weighted efflux rate constant, and k;(t) (min -1) is the effective rate "constant" for phosphory lation of [ 14C]DG in the mixed tissue at any time t. The effec tive rate "constant" for phosphorylation of C4C]DG equals the rate of phosphorylation at time t divided by the concen tr ation of [ 14C]DG in the heterogeneous tissue at time t. In a heterogeneous region, tissues with high rates of metabolism are overrepresented at early times, and tissues with lower met abolic rates are fully represented only at later times. As a con sequence, k'3(t) declines with time and approaches a constant value when all the homogeneous subregions of the mixed tis sue reach equilibrium with the arterial plasma (Schmidt et aI., 1991a) . The TH Model describes the effective rate "constant" k;(t) as k'3(t) = k'3b exp( -k'3ct) where k'3b (min -1) is the effective rate "constant" for phosphorylation of [ 14C]DG at the onset of the experimental procedure and k'3c (min -1) is the rate constant for the exponential decline in k'3(t).
K1' (ml g-J min-I) is the mass-weighted average influx rate constant; kj,<t) and kj(t) (min -I) are the effective rate "constants" for efflux and phosphorylation of [ 14C]DG in the mixed tissue, respectively, at any time t; kia and k�a (min -I) are the mass-weighted average rate constants for efflux and phosphorylation of [ 14C]DG, i.e., the effective rate "constants" when all homogeneous tissues compris ing the mixed tissue reach equilibrium with the arterial plasma; and a (unitless) and [3 (min -I) characterize the decline in the eff�tive rate "constants" kilt) and kj(t).
The parameters K1', kia' k�a' a, and [3 have been esti mated from the time courses of mass-weighted total tissue radioactivity, Ci, both in simulation studies of various mixed tissues in the 1-to 45-min interval following a pulse of [ 14C]DG (Schmidt et aI ., 1991a) and in PET studies of normal human subjects during several time intervals be ginning 0.5 min following a pulse of [ ,sF]FDG (Schmidt et aI., 1992) . In both studies there were also frequent mea surements of total tissue radioactivity at later times; i.e., measurements were made at 5-min intervals beginning 10 or 15 min after administration of the tracer. In the current study, however, there were no very early time data from which the decline in kilt) could be estimated since the first group of animals was killed 3 min after initiation of the experiments . The limited number of samples of total tissue radioactivity at later times also made impractical an accurate estimation of the asymptotic value of the effec tive rate "constant" k�(t). Therefore, a simplified version of the TH Model was used in which the effective rate "constant" for efflux was assumed to be constant and the effective rate "constant" for phosphorylation, k�(t), was assumed to decline asymptotically to zero as a single ex ponential . The TH Model used in the current study ( Fig.  1 C) describes the tissue concentrations of [ 14C]DG and [ '4C]DG-6-P and its further metabolites as follows:
dC� -
where C:, C�, K1', and k�(t) are as already defined; ki (min -I) is the mass-and precursor-pool-weighted efflux rate constant; k�b (min -I) is the effective rate "constant" for phosphorylation of [ 14C]DG at the onset of the exper imental procedure; and k�c (min-I) is the rate constant for the exponential decline in k�(t). Simulation studies of mixed tissues confirmed that the difference between total tissue radioactivity predicted by Eq. 6 and that predicted by Eq . 7 is negligible between 2.5 and 45 min following a pulse of [ 14C]DG. The differences between [ '4C]DG and [ 14C]DG-6-P concentrations predicted by Eqs . 6 and 7 are also small after 2.5 min, and the calculated local cerebral glucose utilization is unaffected by the choice of which TH Model is used (data not shown) .
Rate constant estimations
A weighted nonlinear least-squares procedure, accord ing to the Levenberg-Marquardt method (Press et aI ., 1986) , was used to estimate the rate constants for each of the three models from the measured time courses of total tissue and plasma radioactivity. Arterial plasma [ '4C]DG concentrations were linearly interpolated between sample time points. Concentrations of C: and C�, and partial derivatives of C: and C� with respect to each of the parameters, were calculated by numerical solution of the appropriate differential equations, i.e., Eqs. 4, 5, or 7, by a fourth-order Runge-Kutta procedure with adaptive stepsize control (Press et al., 1986) . Total tissue radioac tivity was computed as the sum of C: and C�, and the partial derivatives of total tissue radioactivity were found by summing the corresponding derivatives for C: and C�.
Weighting factors used in the estimations were the in verses of the measured values for total tissue activity. Rate constants were estimated separately for the pulse and square wave experiments. For the pulse experiments, rate constants were estimated over three time intervals (3-25 min, n = 15; 3-45 min, n = 18; 3-60 min, n = 21) and for the square wave experiments over four time in tervals (3-25 min, n = 16; 3-35 min, n = 19; 3-45 min, n = 22; 3-60 min, n = 26).
Statistics
To test the goodness of fit, i.e., whether the fit of the data by the 4K Model was significantly better than that of the 3K Model and whether the fit of the TH Model was significantly better than that of the 3K Model, an F test for comparison of nested models was used (Landaw and DiStefano, 1984) . The F value was computed as (WRSSI -WRSS2)/(P2 -PI) F = WRSS2/(N _ P2) (measured C� -estimated C�) 2
where the lower the FRSS, the more accurately the model precursor pool in brain. The operational equations for the 3K, 4K, and TH Models were, respectively, those of Sokoloff et al. (1977) , Phelps et al. (1979) , and Schmidt et al. (1991a) . For each model, the rate constants used in the operational equation were those determined in the present study for either the pulse or the square wave animals for each of the time intervals indicated previ ously.
RESULTS
Physiological variables
The physiological variables in all rats included in this study (data not shown) were within normal lim its for this laboratory and similar to those reported previously . Because the rate con stant for transport of e4C]DG across the blood brain barrier is dependent upon the level of the ar terial plasma glucose concentration (Sokoloff et al., 1977) , arterial plasma glucose concentrations were compared fOf all animals. Arterial plasma glucose concentrations ranged from 8.3 ± 0.7 to 9.7 ± 1.1 mM (mean ± SD for each group) in the animals administered a pulse of e4C]DG and from 8.8 ± 0 .2 to 10 .5 ± 1.3 mM in the animals administered a programmed infusion of [14C]DG; values did not dif fer significantly among the groups of animals killed various times after initiation of the experiment (one way analysis of variance) . Therefore, all animals were considered to have the same kinetic parame ters for the purpose of rate constant estimation.
Rate constants and estimated time courses of Cf, C:, and C�: pulse experiments
Following an intravenous pulse of [14C]DG, the values of the rate constants of the 3K Model esti mated from the time courses of total 14C in the tis sue declined with the time following the tracer in jection, whereas the values of the rate constants estimated for the 4K and TH Models were more stable ( Table 1 ) . The estimated value of the rate constant in the 4K Model for dephosphorylation of e4C]DG-6-P, k!, was � 10% of the estimated value of the rate constant for phosphorylation of [14C]DG, kj, when the rate constants were determined over the 45-or 60-min interval after injection of tracer .
The relationships between the time courses of measured total 14C, e4C]DG, and [14C]DG-6-P in the tissue and the time courses estimated with the kinetic models are illustrated in Fig. 2 . Following an intravenous pulse of e4C]DG, the fits of the 3K and TH Models to the time courses of total 14C in the tissue were not significantly different, but the fit of the 4K Model was significantly better than that of the 3K Model in the first 45 min (p < 0.05) (Fig. 2) ; the fit of the 4K Model was also significantly better than that of the 3K Model in the first 60-min interval (p < 0.01) (data not shown) . The 3K Model led to the greatest deviations between measured and esti mated concentrations of e4C]DG and [14C]DG-6-P in the tissue (FRSS = 12 .55) . Even though the TH Model did not fit the time courses of total 14C in the tissue significantly better than did the 3K Model , the TH Model clearly produced better estimates of the concentrations of e4C]DG and e4C]DG-6-P (FRSS = 0.66). The TH Model did not fit the time courses of total 14C in the tissue better than the 4K Model, but the two models produced equally good estimates of the concentrations of e4C]DG and e4C]DG-6-P during the first 45-min interval after injection of tracer (FRSS for 4K Model = 0.60) . The statistically equivalent fits of the time courses of total 14C in the tissue with the 3K and TH Mod els , therefore , did not correlate with correspond ingly equivalent estimates of the time courses of the concentrations of e4C]DG and e4C]DG-6-P in the tissue . Moreover, the TH and 4K Models provided equivalent estimates of the time courses of the con centrations of e4C]DG and e4C]DG-6-P in the tis sue, but only the 4K Model fit the total 14C in the tissue better than did the 3K Model.
Rate constants and estimated time courses of Cr, C:, and C�: square wave experiments
In the animals administered a ramp infusion for 5 min followed by a programmed intravenous infu sion to maintain a constant arterial concentration of e4C]DG, rate constants for the 3K Model did not change with the duration of tracer circulation ( Table  2) . The 4K and TH Models did not improve the fits of the measured time courses of total 14C in the tissue . In fact , the best fits of the latter models (data not shown) were obtained with k! equal to zero (4K Model) or with the kjc decay constant equal to zero (TH Model); in other words, all models became equal to the 3K Model , which is shown in Fig. 3 . In these animals , all models produced an excellent agreement between the time courses of measured and estimated total 14C in the tissue, but still showed a tendency to overestimate the concentra tion of free e4C]DG and underestimate slightly the concentration of [14C]DG-6-P in the tissue (Fig. 3) .
Global rates of glucose utilization
CMRglc values obtained from samples of freeze blown whole rat brain 45 min following a pulse of e4C]DG were �75 tJ.mol 100 g-l min -\ when the no-loss models , i.e., the 3K and TH Models , were used for calculation (Table 3 ) . In contrast, whole brain CMRglc was 108-115 tJ.mol 100 g -1 min -I when the 4K Model was used with rate constants determined in the first 45-60 min following an intra- Values are the means ± SD, CMRglc was calculated with rate constants determined for the pulse and square wave experi ments, respectively, over the time intervals 3-25, 3-35, 3-45, and 3-60 min, respectively, ND denotes not determined, For abbre viations see the text.
a Not significantly different from the square wave experiment conducted in the same time interval (one-way analysis of vari ance, p > 0.05).
b Significantly different from 45-min experimental group given the same mode of tracer administration and analyzed with the same kinetic model (one-way analysis of variance, p < 0,05), , Not significantly different from 45-min experimental group given the same mode of tracer administration and analyzed with the same kinetic model (one-way analysis of variance, p > 0.05), d Significantly different from the square wave experiment con ducted in the same time interval (one-way analysis of variance, p < 0.01). e In the pulse experiments, values for CMRglc calculated with each of the three models are not independent and thus cannot be compared by analysis of variance. A x2-test was used to compare the variability in CMRg1c due to applying each of the three mod els with the variability among the group of animals killed at that time point (see Schmidt et aI., 1989) . At 45 and 60 min, the variance between models was greater than variance among ani mals in the group, indicating a significant difference between the values of CMRglc calculated with the three models.
venous pulse of e4C]DG, >40% higher than CMRglc obtained with the 3K and TH Models (Table 3 ) . In the square wave experiments, when the arterial plasma e4C]DG concentration was maintained at a constant level, whole-brain CMRglc calculated with all kinetic models remained constant at 76-79 fLmol 100 g -1 min -1 between 25 and 45 min after the beginning of the e4C]DG infusion (Table 3) .
DISCUSSION
The kinetic model of the e4C]DG method for the measurement of local rates of cerebral glucose uti lization is applicable to tissues that are homoge neous with respect to rate of blood flow, rates of transport of glucose and e4C]DG between plasma and tissue, concentrations of e4C]DG, glucose, and [14C]DG-6-P, and rate of glucose utilization (Soko loff et al. , 1977) . Subsequently, this model, like many other kinetic models originally developed for use in animals with quantitative autoradiography in which the spatial resolution permits closer approx imation to homogeneity, was applied to heteroge-neous tissues in studies that employ external radi ation detection with much lower spatial resolution, especially PET. With external radiation detection only total tissue radioactivity can be measured, from which the rates (or rate constants) of transfer from one tissue pool to another and the concentra tions of label in individual tissue pools are esti mated. Por example, to evaluate regional rates of cerebral glucose utilization with eSp]PDG and PET, the time course of the eSp]PDG in the tissue and the total amount of eSp]PDG-6-phosphate pro duced during the experimental period must be esti mated. In the determination of regional blood flow with H2150 and PET, the influx rate constant for transport of tracer into the tissue is directly related to the rate of blood flow, and in numerous receptor binding studies, the rate constant for ligand binding to specific receptors is employed as an index of the total number of receptors in a given brain region.
Each of these estimates depends upon the config uration of the kinetic model used for the estimation. One important criterion for selecting among com peting kinetic models has been the comparison of how well each of the kinetic models describes the measured time course of total tissue radioactivity.
The assumption has been that the better the fit to the time course of total tissue radioactivity, the bet ter the description of the time courses of the activity in the individual pools within the tissue and the rates of transfer of the tracer among the pools. As we have shown in the current study, however, the model that provided a poorer fit of total radioactiv ity (in this case, the TH Model in comparison with the 4K Model) provided an equally good description of the concentrations in the individual pools within the tissue. Puthermore, a model that provided a good description of the time courses of the concen trations of label in the individual pools within the tissue (in this study, the 4K Model) did not provide an accurate estimate of the rate of the process of interest. In fact, the 4K Model estimate of CMRg\c was worse than that obtained with the 3K Model, which provided a poor description of the time courses of the concentration of tracer in the precur sor and product pools.
In the case of e4C]DG, simulation experiments have shown that when a kinetic model designed for homogeneous tissue is applied to a heterogeneous tissue, the effective rate constants for efflux and phosphorylation, k! and k'j, initially decline with time and become constant only with long experi mental periods as all the e4C]DG pools in the mixed tissue approach equilibrium with the arterial plasma. The time at which k! and k'j become con stant depends upon the shape of the arterial input and the kinetic constants of the constituent tissues in the heterogeneous sample . In the fitting routines employing the 4K Model, compensation for a de clining kr is achieved by an artificially high k! esti mate and, consequently, an overestimation of re gional CMRg\c values (Schmidt et aI., 199 1a) . The results of the current experimental study confirm our previous simulation results (Tables 1-3 ). Fol lowing an intravenous pulse of e4C]DG, the values of rate constants k! and kr, estimated with the 3K Model by fitting the time courses of total radioac tivity in freeze-blown whole brain, decline with in creasing duration of tracer circulation . The value of the rate constant Kj also declined with an increas ing experimental period, probably due to the high covariance between the estimates for Kj and k!.
The use of the 4K Model lessens the time depen dency of the estimates, particularly the time depen dency of kr, by introducing a k!, the fitted value of which is � 10% of that of kr in the 45-or 60-min interval following a pulse of e4C]DG . The TH Model takes the time dependency of the effective rate con stant kr into account by modeling it as a declining exponential term . Although the TH Model did not fit the total radioactivity in the tissue statistically signif icantly better than did the 3K Model, it provided a much closer description of the concentrations in the e4C]DG and e4C]DG-6-P pools . The 4K Model fitted the measured total radioactivity in the freeze-blown whole brain significantly better than did the 3K Model and provided a good description of the concentrations in the e4C]DG and [14C]DG-6-P pools, but its use led to a large overestimation of CMRglc.
CMRg\c determined from cerebral oxygen con sumption measured by the Kety-Schmidt technique has been reported to be 62 !Lmol 100 g -I min -I in the supratentorium and 77 !Lmol 100 g -I min -1 in cortex of rat brain, whereas CMRglc measured di rectly from arterial-venous differences of glucose was found to be 91 Ilmol 100 g-I min -I in the cor tex of rat brain (see review of Siesj6, 1978) . In pre vious studies in our laboratory, weighted average whole-brain CMRglc determined with the model independent mUltiple-time/graphical analysis tech nique (Patlak et al., 1983; Patlak and Blasberg, 1985) either 25-45 min following a pulse of e4C]DG or 15-60 min after initiation of a programmed infu sion to achieve a constant arterial concentration of e4C]DG was found to be 71 !Lmol 100 g -1 min -I (Mori et aI., 1990) . Therefore, the value of � 75 Ilmol 100 g-I min -I for CMRglc determined in freeze-blown samples of brain in the present study with the 3K or TH Model at 45 min following the pulse of e4C]DG is in good agreement with the rates determined previously by independent methods.
J Cereb Blood Flow Metab, Vol. 15, No . 3, 1995 Whole-brain CMRglc estimated at 45 min with the 4K Model, on the other hand, was 44% higher than the values estimated with the 3K and TH Models and -20% higher even than the rate of glucose uti lization in the cortex determined by independent means. The overestimation of CMRglc with the 4K Model in the experimental time frame used in the current study is a consequence of the high estimate of k! that results from the tissue heterogeneity . A high estimate of k! implies that a significant amount of metabolic product is lost during the experimental period even though the experimental period used in the current study is one in which actual loss of met abolic product has been shown to be insignificant (N elson et aI ., 1987; Mori et aI ., 1990) . When the overestimated lost metabolic product is added to the product remaining in the tissue at the end of the ex perimental period, an overestimate of CMRglc results . When the 4K Model is used as originally designed, i.e., with very long experimental times when true product loss becomes significant, the preceding anal ysis does not apply . In that case, corrections for prod uct loss with the 4K Model and calculated values for CMRglc would need to be experimentally verified.
To minimize the e(fects of metabolic tissue het erogeneity as well as those of possible product loss, a programmed infusion to maintain a constant arte rial concentration of [14C]DG was administered to a separate group of rats. A constant arterial concen tration of tracer serves to lessen the time required for the tissues to reach a steady state with the ar terial plasma. Under steady-state conditions, the ef fective rate "constants" k!(t) and kr(t) approach the averages for the heterogeneous tissue as a whole; i.e., they become true rate constants and the TH Model becomes equivalent to the 3K Model (Schmidt et al, . 199 1a) . The constant arterial con centration of tracer also serves to minimize any ef fects of product loss since both precursor and prod uct pools are continuously replenished. In the cur rent study, approximate steady-state conditions 25, 35, 45, and 60 min after initiation of the pro grammed infusion were evidenced by the failure to detect either heterogeneity or product loss in the fitting of the data; i.e., both the TH and 4K Models reduced to the 3K Model. Rate constants estimated with 3K and 4K Models were different, however, in the animals with the constant arterial input com pared to those administered a pulse of e4C]DG (Ta bles 1 and 2). This is an additional indication that the 3K and 4K Models do not account for important kinetic processes occurring in the tissue . It is more difficult to compare rate constants estimated with the TH Model for the two modes of tracer input.
Estimates of Kj and k! are comparable, but the standard error of the estimates is much greater fol lowing the pulse input . The effective rate "con stant" kj(t), on the other hand , depends upon the concentration of e4C]DG in the precursor pool in the tissue at time t, and that in turn depends upon the history of the concentration of e4C]DG in the arterial plasma (Schmidt et aI., 199 1a) . Therefore , the time courses of kjU) are expected to be different for the two modes of tracer input. Following the pulse of e4C]DG, kj is 0.17 min -I at zero time, but then falls to 0.03 min -I at 45 min. With the constant arterial input, the TH Model collapsed to the 3K Model in which only a single value of kj could be obtained. This single value was found to be 0.08 min -I. As with all modeling efforts, however , the dependence of the estimates of the rate constants upon the configuration of the kinetic model used, the time sampling of the measured data , and the mode of tracer input necessitate caution in attach ing any physiological significance to the estimated values of the rate constants themselves . It is more important to examine how well the model and esti mated rate constants perform in the determination of the rate of glucose utilization . With the constant arterial input, whole-brain rates of glucose utiliza tion were comparable with those determined with the 3K and TH Models in the animals administered a pulse . This provides further evidence that CMR g l c is overestimated with the 4K Model within a 60-min interval following an intravenous pulse of [14C]DG .
The 3K Model was originally designed for applica tion in homogeneous tissues and has now been shown to provide accurate rates of glucose utilization in het erogeneous tissues as well, so long as the experimen tal period is sufficiently long (i.e., 45 min following the pulse of e4C]DG) for the effects of tissue hetrogeneity to be minimized. The current study was performed on awake , unstimulated animals , but the results would be expected to apply equally well to animals undergoing a sustained physiological stimulation. This has been shown in simulation studies, for example , in which regional CMRglc was accurately estimated with the 3K model 45 min following the pulse of [14C]DG in a heterogeneous region that included 10% gray matter tissue with rates of blood flow and metabolism 50% above average (Schmidt et aI., 199 1a) .
One problem with the selection of a model to de scribe the kinetics of a tracer in vivo is that a com monly used statistical test for selecting among com peting models assumes that one of the models is correct; the test may fail if all models used in the comparison include critical incorrect assumptions. Particularly in PET studies, because of the limited spatial resolution , the regions of interest are hetero geneous, and the simplifying assumption of homo-geneity is clearly unwarranted . If the procedure for the measurement of the process of interest is sen sitive to this assumption , errors may become unac ceptably high. As the compartmental models be come increasingly complex and the number of pa rameters and the consequent estimation errors increase , there is more uncertainty about individual compartmental concentrations even in a homoge neous tissue . In such cases , the added effects of heterogeneity must be carefully assessed .
